← 홈

HER2+ 유방암

527개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 527개
ADCBiologicstaleThe First Affiliated Hospital w…Phase 2

Disitamb Vedotin ,pyrotinib (Disitamb Vedotin ,pyrotinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleSanofiPhase 2

Docetaxel (Docetaxel, Docetaxel (T) + bevacizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleHenan Cancer HospitalPhase 3

trastuzumab (Herceptin, Docetaxel+ carboplatin+ trastuzumab + patuzumab)

Breast Cancer,HER2-positive · HER2

#HER2#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleCancer Trials IrelandPhase 2

trastuzumab (Herceptin, Docetaxel, Carboplatin and Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleCancer Trials IrelandPhase 2

trastuzumab (Herceptin, Docetaxel, Carboplatin, Trastuzumab and Lapatinib)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAuxilio Mutuo Cancer CenterPhase 2

trastuzumab (Herceptin, Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab)

Infiltrating Duct and Lobular Carcinoma In Situ; Invasive Lobular Breast Carcinoma · Infiltrating Duct and Lobular Carcinoma

#InfiltratingDuctandLobularCarcin#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 2

trastuzumab (Herceptin, TCH, Docetaxel, carboplatin, trastuzumab, Docetaxel, carboplatin, trastuzumab (TCH) + bevacizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 2

Docetaxel, doxorubicin, cyclophosphamide (TAC, Docetaxel, doxorubicin, cyclophosphamide, Docetaxel, doxorubicin, cyclophosphamide (TAC) + bevacizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleNektar TherapeuticsPhase 2

nivolumab (Opdivo, Dose Escalation Doublet: Combination of NKTR-214 + nivolumab)

Melanoma; Renal Cell Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 64%임상시험 1상태 ACTIVE
AntibodystaleNektar TherapeuticsPhase 2

nivolumab (Opdivo, Dose Expansion Doublet: Combination of NKTR-214 + nivolumab)

Melanoma; Renal Cell Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 64%임상시험 1상태 ACTIVE
AntibodystaleNektar TherapeuticsPhase 2

nivolumab (Opdivo, Dose Expansion Triplet: Combination of NKTR-214+ nivolumab+ ipilimumab)

Melanoma; Renal Cell Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 64%임상시험 1상태 ACTIVE
AntibodystaleAgendiaApproved

trastuzumab (Herceptin, Dose dense AC followed by T + trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAgendiaApproved

trastuzumab (Herceptin, Dose dense AC followed by T + trastuzumab + pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 2

Doxorubicin and cyclophosphamide (AC, Doxorubicin and cyclophosphamide, Doxorubicin and cyclophosphamide (AC) + bevacizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleBeijing BiotechPhase 2

EB-DT-CAR-NK (Dual-target CAR-NK cells, Dual-target CAR-NK cells (EB-DT-CAR-NK))

Breast Cancer (Locally Advanced or Metastatic); HER2-positive Breast Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

Dual-targeting HER2 and PD-L1 CAR-T cells (Dual-targeting HER2 and PD-L1 CAR-T cells)

Peritoneal Carcinoma Metastatic; Pleural Effusion, Malignant · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
AntibodystaleKyoto Breast Cancer Research Ne…Phase 2

Durvalmab&Tremelimumab&Fulvestrant (Durvalmab&Tremelimumab&Fulvestrant)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab + Tremelimumab + metronomic Vinorelbine)

Advanced Solid Tumours; Breast Cancer · Advanced Solid Tumours

#AdvancedSolidTumours#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab with Tremelimumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleFudan UniversityPhase 2

E1: SHR-A1811 (E1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING

17 / 27 페이지

← 이전다음 →